Clinical Trials Browser

INDUSTRY × Carcinoma, Transitional Cell × Immune Checkpoint Inhibitors × Clear all

NCT05775874 2023-03-20

A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Phase 2 Unknown

Carcinoma, Transitional Cell